188 related articles for article (PubMed ID: 23596055)
21. [Preoperative radiochemotherapy of advanced resectable cancer of the oral cavity with cisplatin vs paclitaxel/carboplatin. Analysis of two multimodality treatment concepts].
Eckardt A; Wegener G; Karstens JH
Mund Kiefer Gesichtschir; 2006 Jan; 10(1):30-6. PubMed ID: 16365743
[TBL] [Abstract][Full Text] [Related]
22. E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.
Marur S; Li S; Cmelak AJ; Gillison ML; Zhao WJ; Ferris RL; Westra WH; Gilbert J; Bauman JE; Wagner LI; Trevarthen DR; Balkrishna J; Murphy BA; Agrawal N; Colevas AD; Chung CH; Burtness B
J Clin Oncol; 2017 Feb; 35(5):490-497. PubMed ID: 28029303
[TBL] [Abstract][Full Text] [Related]
23. Matched survival analysis in patients with locoregionally advanced resectable oropharyngeal carcinoma: platinum-based induction and concurrent chemoradiotherapy versus primary surgical resection.
Boscolo-Rizzo P; Gava A; Baggio V; Marchiori C; Stellin M; Fuson R; Lamon S; Da Mosto MC
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):154-60. PubMed ID: 20864267
[TBL] [Abstract][Full Text] [Related]
24. Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck.
Inohara H; Takenaka Y; Yoshii T; Nakahara S; Yamamoto Y; Tomiyama Y; Seo Y; Isohashi F; Suzuki O; Yoshioka Y; Sumida I; Ogawa K
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):934-41. PubMed ID: 25832686
[TBL] [Abstract][Full Text] [Related]
25. Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion.
Worden FP; Moyer J; Lee JS; Taylor JM; Urba SG; Eisbruch A; Teknos TN; Chepeha DB; Prince ME; Hogikyan N; Lassig AA; Emerick K; Mukherji S; Hadjiski L; Tsien CI; Miller TH; Wallace NE; Mason HL; Bradford CR; Wolf GT
Laryngoscope; 2009 Aug; 119(8):1510-7. PubMed ID: 19504552
[TBL] [Abstract][Full Text] [Related]
26. Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results.
Semrau S; Waldfahrer F; Lell M; Linke R; Klautke G; Kuwert T; Uder M; Iro H; Fietkau R
Strahlenther Onkol; 2011 Jan; 187(1):15-22. PubMed ID: 21234526
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.
Rischin D; Young RJ; Fisher R; Fox SB; Le QT; Peters LJ; Solomon B; Choi J; O'Sullivan B; Kenny LM; McArthur GA
J Clin Oncol; 2010 Sep; 28(27):4142-8. PubMed ID: 20697079
[TBL] [Abstract][Full Text] [Related]
28. [Induction chemotherapy using vinorelbine, cisplatin, and UFT in advanced pharyngeo-laryngeal carcinomas: results of a phase II study].
Rubio Suárez A; Teigeiro Núñez V; Gallo Terán J; Señaris González B; Mesuro Domínguez N
Acta Otorrinolaringol Esp; 2003 Dec; 54(10):697-703. PubMed ID: 15164709
[TBL] [Abstract][Full Text] [Related]
29. A prospective comparision of sequential chemoradiation vs concurrent chemoradiation in locally advanced oropharyngeal carcinomas.
Gupta D; Shukla P; Bisht SS; Dhawan A; Pant MC; Bhatt ML; Gupta S; Gupta R; Negi MP
Cancer Biol Ther; 2009 Feb; 8(3):213-7. PubMed ID: 19276670
[TBL] [Abstract][Full Text] [Related]
30. Randomized phase III study of 2 cisplatin-based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: impact of changing disease epidemiology on contemporary trial design.
Rodriguez CP; Adelstein DJ; Rybicki LA; Savvides P; Saxton JP; Koyfman SA; Greskovich JF; Yao M; Scharpf J; Lavertu P; Wood BG; Burkey BB; Lorenz RR; Rezaee RP; Zender CA; Ives DI
Head Neck; 2015 Nov; 37(11):1583-9. PubMed ID: 24909549
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant therapy for organ preservation in head and neck cancer.
Urba SG; Wolf GT; Bradford CR; Thornton AF; Eisbruch A; Terrell JE; Carpenter V; Miller T; Tang G; Strawderman M
Laryngoscope; 2000 Dec; 110(12):2074-80. PubMed ID: 11129024
[TBL] [Abstract][Full Text] [Related]
32. Induction chemotherapy with paclitaxel and cisplatin, followed by concomitant cisplatin and radiotherapy for the treatment of locally advanced nasopharyngeal carcinoma.
Mostafa E; Nasar MN; Rabie NA; Ibrahim SA; Barakat HM; Rabie AN
J Egypt Natl Canc Inst; 2006 Dec; 18(4):348-56. PubMed ID: 18301458
[TBL] [Abstract][Full Text] [Related]
33. Phase I/II study of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck.
Herchenhorn D; Dias FL; Viegas CM; Federico MH; Araújo CM; Small I; Bezerra M; Fontão K; Knust RE; Ferreira CG; Martins RG
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):696-702. PubMed ID: 20421154
[TBL] [Abstract][Full Text] [Related]
34. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant low single dose cisplatin-based concurrent radiochemotherapy of oral cavity and oropharynx carcinoma: impact of extracapsular nodal spread on distant metastases.
Kuhnt T; Klockenbrink U; Knipping S; Lautermann J; Kriese K; Wienke A; Hildebrandt G; Hauptmann S
Strahlenther Onkol; 2011 May; 187(5):292-9. PubMed ID: 21533760
[TBL] [Abstract][Full Text] [Related]
36. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
Thatcher N; Hirsch FR; Luft AV; Szczesna A; Ciuleanu TE; Dediu M; Ramlau R; Galiulin RK; Bálint B; Losonczy G; Kazarnowicz A; Park K; Schumann C; Reck M; Depenbrock H; Nanda S; Kruljac-Letunic A; Kurek R; Paz-Ares L; Socinski MA;
Lancet Oncol; 2015 Jul; 16(7):763-74. PubMed ID: 26045340
[TBL] [Abstract][Full Text] [Related]
37. Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancer.
Dunn LA; Fury MG; Sherman EJ; Ho AA; Katabi N; Haque SS; Pfister DG
Head Neck; 2018 Feb; 40(2):233-241. PubMed ID: 28963790
[TBL] [Abstract][Full Text] [Related]
38. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
39. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
[TBL] [Abstract][Full Text] [Related]
40. Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck : Final 5‑year results of a phase II study.
Kuhnt T; Schreiber A; Pirnasch A; Hautmann MG; Hass P; Sieker FP; Engenhart-Cabillic R; Richter M; Dellas K; Dunst J
Strahlenther Onkol; 2017 Sep; 193(9):733-741. PubMed ID: 28500491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
